Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma
- María del Rocío Herrero Vanrell Directora
- Irene Teresa Molina Martínez Directora
Universitat de defensa: Universidad Complutense de Madrid
Fecha de defensa: 29 de de juny de 2011
- Julián García Feijoo President
- Beatriz de las Heras Polo Secretària
- Virginia Merino Sanjuán Vocal
- Nicolas Tsapis Vocal
- Carmen Álvarez Lorenzo Vocal
Tipus: Tesi
Resum
Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...